JP Morgan Chase’s Agios Pharmaceuticals AGIO Stock Holding History

JP Morgan Chase’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30,000	Closed	-$888K	–	7705
2026 Q1	$888K	Hold	30,000	–	–	﹤0.01%	4680
2025 Q4	$817K	Buy	+30,000	New	+$1.05M	﹤0.01%	4734
2023 Q1	–	Sell	-208,600	Closed	-$5.86M	–	6650
2022 Q4	$5.86M	Buy	+208,600	New	+$5.88M	﹤0.01%	2692
2020 Q2	–	Sell	-55,000	Closed	-$1.95M	–	5336
2020 Q1	$1.95M	Buy	+55,000	New	+$2.54M	﹤0.01%	2983
2019 Q3	–	Sell	-67,100	Closed	-$3.33M	–	5689
2019 Q2	$3.33M	Sell	67,100 -7,900	-11%	-$422K	﹤0.01%	2983
2019 Q1	$5.06M	Buy	+75,000	New	+$4.37M	﹤0.01%	2572
2018 Q4	–	Sell	-30,000	Closed	-$2.31M	–	5662
2018 Q3	$2.31M	Buy	+30,000	New	+$2.41M	﹤0.01%	3352

Other funds holding AGIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

JP Morgan Chase's AGIO Position: Q2 2026 in Review

JP Morgan Chase increased its Agios Pharmaceuticals (AGIO) stake by 137% in Q2 2026, buying an estimated $6.32M and bringing the position to 359,756 shares worth $13.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2528.

JP Morgan Chase first reported a position in AGIO in Q3 2013 and has held it in 52 quarters since. The position peaked at $284M in Q2 2021. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

JP Morgan Chase held 359,756 shares of Agios Pharmaceuticals worth $13.8M as of Q2 2026.
JP Morgan Chase bought 208,198 Agios Pharmaceuticals shares in Q2 2026, an estimated $6.32M.
Agios Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2528 holding.
JP Morgan Chase first reported a position in Agios Pharmaceuticals in Q3 2013 and has held it in 52 quarters since.
JP Morgan Chase's Agios Pharmaceuticals position peaked at $284M in Q2 2021.
238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.